Search Tag: heart failure
2024 14 Oct
According to a new scientific statement from the American Heart Association, three common cardiovascular diseases in adults—heart failure, atrial fibrillation, and coronary heart disease—are closely linked to cognitive decline and an increased risk of dementia. The statement reviews current research on the relationship between cardiovascular and brain...Read more
2024 07 Oct
Heart failure is an escalating global health challenge that can be difficult to manage. Tools like guideline-directed medical therapy (GDMT) offer promising ways to improve outcomes. New research led by UCLA emphasises the critical role these guidelines play in reducing mortality rates for individuals with heart failure with reduced ejection...Read more
2024 30 Sep
A study using clinical trial data has identified a higher risk of stroke, heart attack, and hospitalisations for heart failure among older cancer survivors. Published in Cancer, the analysis also linked chemotherapy to increased rates of these cardiovascular conditions. While advancements in cancer treatments have reduced mortality rates over...Read more
2024 26 Aug
According to a new study, the anti-obesity drug semaglutide may help prevent heart attacks and other major cardiac events in overweight individuals with cardiovascular disease, whether or not they also have heart failure. The study is published in The Lancet. This research builds on previous findings, which showed that weekly injections of semaglutide...Read more
2024 30 Jul
Patients with congestive heart failure (CHF) who have impaired blood supply are at a higher risk of sudden cardiac death (SCD), with an estimated incidence of up to 22%. Current clinical guidelines recommend implantable cardioverter defibrillators (ICDs) to reduce this risk. However, these guidelines are based on studies that did not include individuals...Read more
2024 24 Jun
Semaglutide has demonstrated significant symptom improvement in both men and women suffering from a common type of heart failure with limited treatment options. Research presented at the American Diabetes Association’s 2024 Scientific Sessions and published in the Journal of the American College of Cardiology reveals that women achieved greater...Read more
2024 30 May
Recent research presented at Heart Failure 2024 highlights that semaglutide reduces the necessity for loop diuretics and their dosage while also positively impacting symptoms, physical limitations, and body weight in patients with heart failure with preserved ejection fraction (HFpEF), irrespective of their diuretic regimen. HFpEF occurs when the...Read more
2024 28 May
Recent research indicates that heart failure induces a lasting stress memory in the body, potentially contributing to recurrent heart failure and other health issues. This memory involves changes to the DNA modifications of haematopoietic stem cells, which are crucial for producing immune cells like macrophages that protect heart health. During...Read more
2024 14 May
According to research presented at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC), heart failure patients vaccinated against COVID-19 are 82% more likely to survive than their unvaccinated counterparts. While previous research has confirmed the safety of COVID-19 vaccines in patients with cardiovascular...Read more
2024 17 Aug
<marquee behavior="slide" direction="left" scrollamount="30"><h2 style="text-align: center;"><font color="#000099"><b>Find Mato Clinic On Social Media</b> </font></h2><div style="text-align: center;"><a href=https://twitter.com/MayoClinicCV target="_blank"><img src="/uploads/twnew.png" style="text-align: initial;" width=65 height=65>Read more
2024 07 Feb
A new study has paved the way for a groundbreaking approach to identifying patients with acute decompensated heart failure (ADHF) who may have a poor response to diuretic therapy. Published in the Journal of the American College of Cardiology, Heart Failure , the research introduces a machine learning-based phenomapping method and diuresis score...Read more
2024 07 Feb
A new study has paved the way for a groundbreaking approach to identifying patients with acute decompensated heart failure (ADHF) who may have a poor response to diuretic therapy. Published in the Journal of the American College of Cardiology, Heart Failure , the research introduces a machine learning-based phenomapping method and diuresis score...Read more
2024 07 Feb
A new study has paved the way for a groundbreaking approach to identifying patients with acute decompensated heart failure (ADHF) who may have a poor response to diuretic therapy. Published in the Journal of the American College of Cardiology, Heart Failure , the research introduces a machine learning-based phenomapping method and diuresis score...Read more
2024 30 Jan
Over half of the U.S. population (51%) remains unaware that heart disease is the leading cause of death, as per a recent Harris Poll survey conducted by the American Heart Association. This lack of awareness persists despite heart disease maintaining its status as the number one killer for over a century. Heart Disease and Stroke Statistics report...Read more
2023 13 Dec
A renowned expert in cardio-oncology and heart failure, Michelle Bloom, MD, has joined NYU Langone Health as system director of the Cardio-Oncology Program, which provides specialized care to protect patients’ heart health throughout cancer treatment and survivorship. Dr. Bloom is a professor in the Department of Medicine and a member of the Division...Read more
2023 07 Nov
Agamon Health's Patient Adherence platform is aimed at raising standards of cardiovascular care Agamon Health is a healthcare technology company that uses Generative AI and workflow automation to close gaps in patient care. In collaboration with Mayo Clinic through a know-how agreement, Agamon Health aims to extend its offering to cardiology....Read more
2023 26 Aug
Late-breaking research presented at ESC Congress 2023 reveals that qiliqiangxin, a traditional Chinese medicine, effectively reduces hospitalisations due to heart failure and cardiovascular-related deaths among patients suffering from heart failure and reduced ejection fraction (HFrEF). Derived from a blend of 11 distinct herbs, qiliqiangxin...Read more
2023 25 Aug
In recent breakthrough research presented during a Hot Line session at ESC Congress 2023, semaglutide's effectiveness in improving symptoms and physical function related to heart failure and inducing greater weight loss was reported. Nearly 50% of heart failure patients are affected by heart failure with preserved ejection fraction (HFpEF)....Read more
2023 01 Aug
A recent study reports that individuals with heart failure who increased their daily step count experienced notable improvements in their health status during a 12-week period. Consumer wearable devices to track health status and progress have become increasingly popular. However, interpreting data from these devices, including step count,...Read more
2023 28 Jun
The AI4HF project was recently launched in Utrecht, the Netherlands. The project is designed to pioneer the development of the first reliable artificial intelligence (AI) model for managing heart failure patients. The initiative is led by a consortium of global partners, including the European Society of Cardiology (ESC). Professor Folkert Asselbergs,...Read more
2023 20 Apr
Vasopressors and inotropes are frequently used in intensive care units. With a special focus on recent studies, this article summarises the key messages in the management of patients requiring inotropes and vasopressors. Introduction Cardiac output (CO) is a key determinant of oxygen delivery. Low cardiac output syndrome (LCOS) causes...Read more
2023 30 Nov
<marquee behavior="slide" direction="left" scrollamount="30"><h2 style="text-align: center;"><font color="#000099"><b>Find Scientex Conferences On Social Media</b> </font></h2><div style="text-align: center;"> <a href=https://twitter.com/scientexevents target="_blank"><img src="/uploads/twnew.png" style="text-align: initial;" width=85 hRead more
2022 14 Oct
An overview of the clinical evidence demonstrating the effectiveness of landiolol for the treatment of atrial fibrillation or atrial flutter with heart failure and effective heart rate control during arrhythmias. Supraventricular arrhythmias (SVTs) are common in post-operative and cardiac ICUs. SVTs increase the risk of death...Read more
2022 14 Oct
An overview of the clinical evidence demonstrating the effectiveness of landiolol for the treatment of atrial fibrillation or atrial flutter with heart failure and effective heart rate control during arrhythmias. Supraventricular arrhythmias (SVTs) are common in post-operative and cardiac ICUs. SVTs increase the risk of death...Read more